Vanessa Wookey

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma”.

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

P-70 Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma: Multi-center single institution cohort experience

Annals of Oncology(2022)10.1016/j.annonc.2022.04.160

N/A

0DataRank · unranked

0 citations

Vanessa Wookey, Tyler Zemla, Q. Shi, Tanios Bekaii‐Saab, Nguyen H. Tran +2 more

Survival outcomes of adjuvant treatment in upstaged clinical T2N0 rectal cancer: are we underutilizing therapy?

Journal of Gastrointestinal Surgery(2024)10.1016/j.gassur.2024.10.024

N/A

0DataRank · unranked

0 citations

Caroline Westwood, Jill Hasler, Vanessa Wookey, Andrea S. Porpiglia, Stephanie H. Greco +5 more